Silvec Biologics, Inc.
Gaithersburg, MD Silvec Biologics
- UEI
- ZH7KBVHXP1C3
- CAGE
- 8LAV6
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 200 Girard St #200, Gaithersburg, MD 20877, USA
- Website
- silvec.com
- Founded
- 2019
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Delivery of sirna-containing tetrahedral RNA nanostructures into bioenergy crops using LDH stabilized sprays | Office of Science | $256,500 | |
| Sbir phase II: using a novel RNA therapy to immunize trees and vines against deadly bacteria -the broader… | National Science Foundation | $994,939 | |
| **awards issued prior to january 20, 2025, were funded under previous administrations and may not reflect the priorities… | Institute of Food Production and Sustainability | $650,000 | |
| SP: molecular strategies to block psyllid transmission of the huanglongbing (HLB) pathogen | Central Program Planning Coordination and Support | $421,489 | |
| Trees, vines, and bushes are plagued by pathogens causing over $100B in annual damage. Fungi are of particular… | Institute of Food Production and Sustainability | $174,964 |
About Silvec Biologics, Inc.
Silvec Biologics, Inc. is a biotechnology company located in Gaithersburg, Maryland, that specializes in developing innovative RNA interference (RNAi) technologies for agricultural applications. The company focuses on creating novel RNA therapies designed to protect agricultural crops against devastating bacterial, viral, and fungal pathogens through advanced gene silencing techniques. Registered in SAM.gov since April 30, 2020, Silvec Biologics operates as a for-profit corporate entity and has established itself as a pioneering research organization in the field of plant disease prevention using cutting-edge molecular technologies.
Through multiple federal grant awards from agencies like the National Science Foundation (NSF), Department of Agriculture (USDA), and Department of Energy, Silvec Biologics has consistently pursued research to develop RNA-based solutions for agricultural challenges. The company's primary work involves creating small interfering RNA (siRNA) technologies to combat specific plant diseases, including citrus greening (Huanglongbing), Xylella fastidiosa infections, grapevine red blotch virus, and various fungal diseases affecting crops like grapevines. Their research has focused on developing proprietary internally-delivered virus-like RNA (iRNA) vector systems that can generate siRNAs to silence critical pathogen genes. Notably, Silvec has worked closely with the University of Maryland as a collaborative partner, receiving sub-awards to support research into gene silencing systems. The company's grant-funded projects have typically ranged from $174,964 to $994,939, with research periods spanning one to two years, demonstrating a consistent commitment to innovative agricultural biotechnology solutions that could potentially revolutionize crop protection strategies.
Quick answers
What is Silvec Biologics, Inc.'s UEI?
Silvec Biologics, Inc.'s Unique Entity ID (UEI) in SAM.gov is ZH7KBVHXP1C3.
What is Silvec Biologics, Inc.'s CAGE code?
Silvec Biologics, Inc.'s CAGE code is 8LAV6.
Where is Silvec Biologics, Inc. located?
Silvec Biologics, Inc.'s physical address in SAM.gov is 200 Girard St #200, Gaithersburg, MD 20877, USA.
Is Silvec Biologics, Inc. registered in SAM.gov?
Yes. Silvec Biologics, Inc.'s SAM.gov registration is active through September 2, 2027.
What is Silvec Biologics, Inc.'s most recent federal award?
Silvec Biologics, Inc.'s most recent federal grant award is Delivery of sirna-containing tetrahedral RNA nanostructures into bioenergy crops using LDH stabilized sprays (DESC0025759), from Office of Science, on February 18, 2025.
On GovTribe
See Silvec Biologics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors